Brief: China Resources Pharmaceutical Announces KPC Pharmaceuticals FY Results
11/03/2025 13:10
March 11 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK: KPC PHARMACEUTICALS PROPOSED TO DISTRIBUTE CASH DIVIDEND OF RMB3.00 PER 10 SHARES FY REVENUE FOR KPC PHARMACEUTICALS RMB8.40 BILLION FY NET PROFIT ATTRIBUTABLE FOR KPC PHARMACEUTICALS RMB648.1 MILLION Further company coverage: 3320.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals